Last updated: August 11, 2021
Sponsor: National Research Centre, Egypt
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pregnancy Complications
Treatment
N/AClinical Study ID
NCT03838887
placental vascular indices
Ages 18-35 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- A. Control group: Pregnant women:
- Age between 18-35 years
- Parity: primigravidas and multiparas.
- Have no history of preeclampsia or eclampsia.
- Have no history of chronic hypertension.
- Not diabetic.
- Not have antiphospholipid syndrome.
- Not have autoimmune disease such as SLE. B. High risk group: Pregnant women with:
- History of preeclampsia -Eclapmsia
- Chronic hypertension
- Diabetic
- Antiphospholipid syndrome.
- Autoimmune syndrome such as SLE.
Exclusion
Exclusion Criteria:
- • Smoking
- Dichorionic placentae
- Fetal anomaly
- Uterine fibroid at the site of placental implantation
- Subchorionic hematoma
Study Design
Total Participants: 100
Study Start date:
June 01, 2021
Estimated Completion Date:
January 01, 2022
Study Description
Connect with a study center
National Research Centre
Cairo, 1234
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.